SouthState Corp’s Takeda Pharmaceutical TAK Stock Holding History

SouthState Corp’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$15.5K	–	1592
2025 Q2	$15.5K	Buy	+1,000	New	+$14.8K	﹤0.01%	704

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

SouthState Corp's TAK Position: Q3 2025 in Review

SouthState Corp sold out of Takeda Pharmaceutical (TAK) in Q3 2025, closing a stake of 1,000 shares — an estimated $15.5K sold.

SouthState Corp first reported a position in TAK in Q2 2025 and held it in 1 quarter. The position peaked at $15.5K in Q2 2025. 329 funds tracked by Wall St. Rank hold TAK as of Q3 2025.

SouthState Corp reported no remaining Takeda Pharmaceutical position as of Q3 2025 after selling out during the quarter.
SouthState Corp sold 1,000 Takeda Pharmaceutical shares in Q3 2025, an estimated $15.5K.
SouthState Corp first reported a position in Takeda Pharmaceutical in Q2 2025 and held it in 1 quarter.
SouthState Corp's Takeda Pharmaceutical position peaked at $15.5K in Q2 2025.
329 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2025.

Based on SouthState Corp's 13F filing for Q3 2025, filed 5 Nov 2025.